Pharmacyclics Inc

(NASDAQ: PCYC)
  • Trade now
  • Add to Watchlist
  • Get Chart
  • Print report
84.89 Up +0.97 +1.16%
Find financial results for:
 Annual  Interim
2012 2012 2011 2010 2009
Period End Date 12/31/2012 06/30/2012 06/30/2011 06/30/2010 06/30/2009
Period Length 6 Months 12 Months 12 Months 12 Months 12 Months
Stmt Source 10-K 10-K 10-K 10-K 10-K
Stmt Source Date 02/26/2013 02/26/2013 02/26/2013 02/26/2013 09/22/2009
Stmt Update Type Updated Reclassified Reclassified Reclassified Updated
           
Net Income/Starting Line 117.53 11.99 -35.2 -15.02 -23.45
Depreciation/Depletion 0.6 0.56 0.29 0.24 0.3
Amortization 0.0 0.0 0.0 0.0 0.0
Deferred Taxes 0.0 0.0 0.0 0.0 0.0
Non-Cash Items
7.45 9.99 8.7 3.63 3.81
Accounting Change 0.0 0.0 0.0 0.0 0.0
Unusual Items 0.01 0.03 0.01 0.0 -0.01
Other Non Cash Items 7.44 9.96 8.69 3.63 3.83
Changes in Working Capital
-14.88 63.55 3.94 -4.31 11.16
Prepaid Expenses 1.03 -3.31 -0.26 -1.14 0.05
Other Operating Cash Flow 0.0 0.0 -0.01 0.0 0.0
Accrued Expenses 6.5 1.87 2.9 1.65 0.01
Accounts Receivable -20.77 -5.88 0.15 0.43 -0.63
Payable/Accrued 0.0 0.0 0.0 0.0 0.0
Taxes Payable 1.39 0.0 0.0 0.0 0.0
Accounts Payable 1.56 2.21 -0.1 0.29 0.11
Other Liabilities -4.58 68.66 1.26 -5.55 11.62
Cash from Operating Activities 110.69 86.09 -22.27 -15.47 -8.18
           
Capital Expenditures
-2.42 -2.98 -1.15 -0.22 -0.08
Purchase/Acquisition of Intangibles 0.0 0.0 0.0 0.0 0.0
Purchase of Fixed Assets -2.42 -2.98 -1.15 -0.22 -0.08
Other Investing Cash Flow Items, Total
-3.97 18.78 -2.5 -21.59 2.74
Intangibles, Net 0.0 0.0 0.0 0.0 0.0
Sale of Fixed Assets 0.0 0.0 0.0 0.0 0.01
Sale Maturity of Investment 1.68 24.5 75.46 15.01 7.7
Purchase of Investments -5.65 -5.72 -77.96 -36.6 -4.97
Cash from Investing Activities -6.39 15.81 -3.65 -21.81 2.66
           
Financing Cash Flow Items
0.0 0.0 0.0 0.0 0.0
Other Financing CashFlow 0.0 0.0 0.0 0.0 0.0
Total Cash Dividends Paid 0.0 0.0 0.0 0.0 0.0
Issuance (Retirement) of Stock, Net 5.23 8.24 62.48 74.26 1.39
Issuance (Retirement) of Debt, Net 0.0 0.0 0.0 -0.31 6.4
Cash from Financing Activities 5.23 8.24 62.48 73.94 7.79
           
Foreign Exchange Effects 0.0 0.0 0.0 0.0 0.0
Net Change in Cash 109.54 110.14 36.56 36.67 2.27
           
Net Cash - Beginning Balance 197.9 87.76 51.2 14.53 12.26
Net Cash - Ending Balance 307.43 197.9 87.76 51.2 14.53

Financial data in USD
Values in Millions (Except for per share items)

Business Type: Industry

Financial statements are prepared in this standard format to allow direct comparisons of all companies and industries across multiple time frames.

See 10K and 10Q SEC Filings for as reported statements

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.